MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Osteosarcoma is a primary bone tumor predominantly affecting young individuals, characterized by complex pathogenesis and treatment resistance.
• MicroRNAs (miRNAs) are key regulators of gene expression, influencing cellular processes through mRNA targeting.
• The role of specific miRNAs, like miR-217, in osteosarcoma development and progression requires further elucidation.

Purpose of the Study:

• To investigate the expression levels and functional role of miR-217 in osteosarcoma.
• To identify downstream targets of miR-217 involved in osteosarcoma pathogenesis.
• To evaluate the therapeutic potential of miR-217 in osteosarcoma.

Main Methods:

• Quantitative real-time PCR was used to assess miR-217 expression in osteosarcoma cell lines and tissues.
• Cell proliferation, migration, and invasion assays were performed to evaluate the functional impact of miR-217.
• Western blotting and luciferase reporter assays were employed to identify and validate WASF3 as a direct target of miR-217.

Main Results:

• miR-217 expression was significantly downregulated in osteosarcoma tissues and cell lines compared to normal controls.
• Lower miR-217 levels correlated with increased metastasis in osteosarcoma patients.
• Overexpression of miR-217 suppressed osteosarcoma cell proliferation, migration, and invasion, while inhibition accelerated these processes.
• WASF3 was identified as a direct target of miR-217, and its ectopic expression partially rescued the anti-tumor effects of miR-217.

Conclusions:

• miR-217 acts as a tumor suppressor miRNA in osteosarcoma.
• miR-217 inhibits osteosarcoma cell proliferation, migration, and invasion, at least partly through the downregulation of WASF3.
• Targeting miR-217 or its downstream effector WASF3 may represent a novel therapeutic strategy for osteosarcoma.